Nano Letters · 2021 · 62 citations · 25 references
MedicineCell BiologyOncologyMolecular DiagnosticsMolecular OncologyProteomicsCancer BiomarkersCancer Molecular DiagnosticsCell ClusteringExosome AnalysisProteomic BiomarkersProteomic ProfilingClusteringEarly DiagnosisExosomal BiomarkersExosomal Protein AnalysisExosome Protein BiomarkersExosome-based Disease DiagnosticsExosomesExosomes In Cancer
Exosomes have recently emerged as some of the most promising biomarkers for disease diagnosis. Due to their small sizes and composition heterogeneity, exosomes are difficult to detect by currently available platforms. Here, we report a pH-mediated assembly system that converts single nanosized exosomes into microsized clusters, which can be directly analyzed by conventional flow cytometry (FCM), breaking through the size limit of exosome analysis. We demonstrated the clinical utility of the pH-mediated clustering system by profiling the exosomal proteins from blood plasma samples of 33 cancer patients and 11 benign controls. The results indicated that the combination of MUC-1 and PD-L1 could serve as a new biomarker panel for the early diagnosis of liver cancer with high clinical accuracy. This pH-mediated assembly strategy allows rapid, sensitive, and high-throughput analysis of exosome biomarkers by conventional FCM, which can be easily refined for use in both basic and clinical settings.
25
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sónia A. Melo, Linda B. Luecke, Christoph Kahlert et al. · Nature · 2015 · 2.9K citations · Full text
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C. Huang, Wei Zhang et al. · Nature · 2018 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +14
Edwin van der Pol, Frank A. W. Coumans, Anita E. Grootemaat et al. · Journal of Thrombosis and Haemostasis · 2014 · 932 citations · Full text
Jason Webber, Aled Clayton · Journal of Extracellular Vesicles · 2013 · 794 citations · Full text